These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29528883)

  • 41. Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia.
    Jarema M; Bieńkowski P; Heitzman J; Parnowski T; Rybakowski J
    Psychiatr Pol; 2017 Feb; 51(1):7-21. PubMed ID: 28455891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Case Report: Paliperidone Palmitate, But Not Aripiprazole, as a Possible Risk Factor for Pulmonary Embolism.
    Michaud I; Landry P
    J Clin Psychopharmacol; 2018 Aug; 38(4):392-394. PubMed ID: 29746335
    [No Abstract]   [Full Text] [Related]  

  • 43. Improvement in psychotic symptoms and social functioning after augmentation of paliperidone with clozapine in a patient with schizoaffective disorder.
    Hou YC
    J Neuropsychiatry Clin Neurosci; 2014; 26(1):E26. PubMed ID: 24515699
    [No Abstract]   [Full Text] [Related]  

  • 44. The current data on the 3-month paliperidone palmitate formulation for the treatment of schizophrenia.
    Bioque M; Bernardo M
    Expert Opin Pharmacother; 2018 Oct; 19(14):1623-1629. PubMed ID: 30244607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement.
    Muser E; Kozma CM; Benson CJ; Mao L; Starr HL; Alphs L; Fastenau J
    J Med Econ; 2015; 18(8):637-45. PubMed ID: 25851616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid onset of treatment effects on psychosis, depression, and mania in patients with acute exacerbation of schizoaffective disorder following treatment with oral extended-release paliperidone.
    Fu DJ; Turkoz I; Bossie CA; Patel H; Alphs L
    J Affect Disord; 2016 Mar; 193():381-90. PubMed ID: 26802315
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Efficacy, tolerability and safety of paliperidone extended-release in the treatment of schizophrenia and schizoaffective disorder].
    Bellantuono C; Santone G
    Riv Psichiatr; 2012; 47(1):5-20. PubMed ID: 22358213
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tolerability of paliperidone: a meta-analysis of randomized, controlled trials.
    Harrington CA; English C
    Int Clin Psychopharmacol; 2010 Nov; 25(6):334-41. PubMed ID: 20706126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complete atrioventricular block in a young schizophrenia patient.
    Dias FC; Prais HC; Lisboa da Silva RM; Correa H
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E30-1. PubMed ID: 20463140
    [No Abstract]   [Full Text] [Related]  

  • 50. [Therapy of psychotic schizophrenia spectrum disorders in adolescents].
    Popov YV; Yakovleva YA; Pisevich MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):47-50. PubMed ID: 26525621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of Paliperidone Palmitate and Second-Generation Oral Antipsychotics in Terms of Medication Adherence, Side Effects, and Quality of Life.
    Sağlam Aykut D
    J Clin Psychopharmacol; 2019; 39(1):57-62. PubMed ID: 30566417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Atrioventricular block induced by high doses of risperidone].
    Rodríguez-García E; Ozcariz-Collar L
    Farm Hosp; 2008; 32(4):249-50. PubMed ID: 19128732
    [No Abstract]   [Full Text] [Related]  

  • 53. Paliperidone-Associated Hyponatremia: Report of a Fatal Case With Analysis of Cases Reported in the Literature and to the US Food and Drug Administration Adverse Event Reporting System.
    Mazhar F; Carnovale C; Haider N; Ahmed R; Taha M
    J Clin Psychopharmacol; 2020; 40(2):202-205. PubMed ID: 32068565
    [No Abstract]   [Full Text] [Related]  

  • 54. Acute psychosis in a polyglot: Linguistic regression to the mother tongue and restoration.
    Saito S
    Asian J Psychiatr; 2019 Jun; 43():91-92. PubMed ID: 31112897
    [No Abstract]   [Full Text] [Related]  

  • 55. Accidental Pediatric Paliperidone Ingestion Resulting in Delayed Profound Tachycardia.
    Borek HA; Charlton NP
    J Emerg Med; 2019 Oct; 57(4):e109-e111. PubMed ID: 31591075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Olanzapine as a possible replacement choice for paliperidone-induced Pisa syndrome: a case report.
    Tsou CC; Huang SY
    Australas Psychiatry; 2016 Dec; 24(6):545-547. PubMed ID: 27590078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paroxysmal perceptual alteration in a schizophrenic patient treated with paliperidone: A case report.
    Benna P; Rubino E; Marino C; Montalenti E; Giovanna Caprioli M; Rainero I; Pinessi L
    Ann Clin Psychiatry; 2015 Aug; 27(3):223-4. PubMed ID: 26247222
    [No Abstract]   [Full Text] [Related]  

  • 58. Hypersexuality associated with paliperidone.
    Çayköylü A; Karslıoğlu EH; Özer İ; Köksal AG
    Exp Clin Psychopharmacol; 2018 Apr; 26(2):109-112. PubMed ID: 29389211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate.
    Potkin SG; Loze JY; Forray C; Baker RA; Sapin C; Peters-Strickland T; Beillat M; Nylander AG; Hertel P; Nitschky Schmidt S; Eramo A; Hansen K; Naber D
    Int J Neuropsychopharmacol; 2017 Jan; 20(1):40-49. PubMed ID: 27927736
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hospitalizations and economic analysis in psychotic patients with paliperidone palmitate long-acting injection.
    Mesones-Peral JE; Gurillo-Muñoz P; Sánchez-Sicilia MP; Miller A; Griñant-Fernández A
    Rev Psiquiatr Salud Ment; 2017; 10(1):33-37. PubMed ID: 27053545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.